Spiller, Robin
Major, Giles
Article History
First Online: 26 September 2016
Competing interests
: R.S. has received research funding from Ironwood and Lesaffre and free drug for clinical trial from Falk Pharma and Norgine. He has also acted on Advisory Boards for Allergan, Almirall, Astellas, Danone and Yuhan. G.M. declares no competing interests.